COX-2/DHODH双重抑制剂存在可行性的初步对接虚拟筛选研究

李顺来;李秀艳;杜洪光

北京化工大学学报(自然科学版) ›› 2008, Vol. 35 ›› Issue (6) : 25-29.

PDF(1939 KB)
欢迎访问北京化工大学学报(自然科学版),今天是 2025年4月5日 星期六
Email Alert  RSS
PDF(1939 KB)
北京化工大学学报(自然科学版) ›› 2008, Vol. 35 ›› Issue (6) : 25-29.
化学与化学工程

COX-2/DHODH双重抑制剂存在可行性的初步对接虚拟筛选研究

  • 李顺来;李秀艳;杜洪光
作者信息 +

Feasibility study of the existence of dual inhibitors of COX-2/DHODH based on virtual screening

  • LI ShunLai;LI XiuYan;DU HongGuang
Author information +
文章历史 +

摘要

首次开展了探索环氧合酶-2(COX-2)和二氢乳清酸脱氢酶(DHODH)双重抑制剂存在的可行性研究工作。通过自建COX-2抑制剂数据库,采用虚拟筛选方法,以DHODH的晶体结构为靶标,对建的COX-2抑制剂数据库进行对接虚拟筛选,筛选出多个对DHODH可能有抑制作用并且具有COX-抑制活性的分子。研究表明,现有数据库中的25000系列、7000系列、26000系列以及33000系列的抑制剂最有可能成为DHODH和COX-2的双抑制剂,特别是其中的2500、7004和7006这三个抑制剂,具有进一步实验研究的价值。

Abstract

A feasibility study of the existence of dual inhibitors of COX2/DHODH has been
explored for the first time. We constructed a database with inhibitor structure
s and activities (IC-50 or log1/C) using 773 inhibitors of COX-2. Based on
the crystal structure of DHODH (PDB code: 1d3h), virtual screening was performe
d against the constructed database. Taking into account docking energy and the molecular activities of COX2, some compounds were selected. It was found that the inhibitors of series 25000, 7000, 26000 and 33000 are possible dual i
nhibitors of COX2/DHODH and the compounds 25002, 7004, 7006, in particul
ar, have potential value for real bioassays.

引用本文

导出引用
李顺来;李秀艳;杜洪光. COX-2/DHODH双重抑制剂存在可行性的初步对接虚拟筛选研究[J]. 北京化工大学学报(自然科学版), 2008, 35(6): 25-29
LI ShunLai;LI XiuYan;DU HongGuang. Feasibility study of the existence of dual inhibitors of COX-2/DHODH based on virtual screening[J]. Journal of Beijing University of Chemical Technology, 2008, 35(6): 25-29

参考文献

[1]Kurumbail R G, Stevens A M, Gierse J K, et al. Structural basis for selective inhibition of cyclooxygenase2 by antiinflammatory agents[J]. Nature,1997, 384: 644-648.
[2]Uiu S, Neidhardt E A, Grossman T H, et al. Structures of human dihydrooro
tate dehydrogenase in complex with antiproliferative agents[J]. Structure Fold
Des, 2000, 8: 25-33.
[3]Lyne P D. Structurebased virtual screening: An overview[J]. Drug
Discov Today, 2002, 7: 1047-1055.
[4]Zsolt Z, Darryl R, Aniko S, et al. eHiTS: An innovative approach to the docking and scoring function problems[JP2][J]. Current Protein and Peptide Science,2006, 7: 421-[JP]435. 
[5]Zsolt Z, Darryl R, Aniko S, et al. eHiTS: A new fast, exhaustive flexible
ligand docking system[J]. J Mol Grap Mode, 2007,26(1):198-212. 
[6]Tímea P, Csaba M, Istvn S, et al. Impact of Ligand Protonation on Virtua
l Screening againstSecretase [JP2](BACE1) [J]. J Chem Inf Model, 2007,47 (6):2366-[JP]2373. 
[7]〓Englebienne P, Fiaux H, Kuntz D, et al. Evaluation of docking programs fo
r predicting binding of Golgi alphamannosidase II inhibitors: A comparison wit
h crystallography[J]. Proteins, 2007,69(1):160-176.
[8]Carlson R P. Newer immunosuppressive drugs and other agents for the treatment of rheumatoid arthritisAn update[J]. Exp Opin Invest Drugs,1995, 4(9):
853-859.
[9]Elizabeth A K, Philip T H, David P K, et al. Synthesis, StructureActivi
ty Relationships, and Pharmacokinetic Properties of Dihydroorotate DehydrogenaseInhibitors: 2Cyano3cyclopropyl3hydroxyN[3′methyl4′(trifl
uoromethyl)phenyl]propenamide and Related Compounds[J]. J Med Chem,1996, 39(23): 4608-4621.〖ZK)〗
[10]Thompson M. A. ArgusLab 4.0.1[CP/OL]. Seattle, WA: Planaria Software LLC, 2004, [20070328]. http:∥www.arguslab.com.
[11]Wallace A C,Laskowski R A,Thornton J M. LIGPLOT: A program to generate schematic diagrams of proteinligand interactions[J]. Prot Eng,1995, 8: 127-134.

PDF(1939 KB)

3136

Accesses

0

Citation

Detail

段落导航
相关文章

/